THERAPY PROGRAM: Multiple Sclerosis
CME Credit: 2.0 hours
Program Director: Andrew D. Goodman, MD, FAAN, Rochester, NY
Understand the evidence regarding the potential risks and benefits of fampridine and commonly used complementary and alternative medicines for multiple sclerosis (MS), and be able to prescribe disease-modifying therapies consistent with an evidence-based approach.
Program Description
Therapeutic options for multiple sclerosis have expanded dramatically in the past decade. In this session faculty will focus on randomized controlled trials demonstrating the safety and efficiency of fampridine, which can improve motor function and other symptoms of MS; the rationale and evidence for complementary and alternative medicines commonly used by patients with MS, and practical management of disease activity and symptoms using interactive cases.
Recommended Audience
- Practitioners
- Clinical Researchers
- Residents
Core Competencies
- Medical Knowledge
- Patient Care
- Practice-Based Learning and Improvement
Schedule and Faculty
| Friday, January 16 / 6:00 p.m. – 8:00 p.m. | ||
|---|---|---|
| Fampridine: A Restorative Treatment for Multiple Sclerosis | Andrew D. Goodman, MD, FAAN | Rochester, NY |
| Complementary and Alternative Medicine for Multiple Sclerosis | Allen C. Bowling, MD, PhD | Englewood, CO |
| Management of Multiple Sclerosis: Illustrative Cases | Andrew D. Goodman, MD, FAAN | Rochester, NY |
